Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Original Article

The association of the serum levels of myostatin, follistatin, and interleukin-6 with sarcopenia, and their impacts on survival in patients with hepatocellular carcinoma

Kanghyug Choi, Hee Yoon Jang, Joong Mo Ahn, Sung Ho Hwang, Jung Wha Chung, Yun Suk Choi, Jin-Wook Kim, Eun Sun Jang, Gwang Hyeon Choi, Sook-Hyang Jeong

Clin Mol Hepatol. 2020;26(4):492-505. Published online July 10, 2020

DOI: https://doi.org/10.3350/cmh.2020.0005

View: 13460 Download: 304 Web of Science: 38 Crossref: 37

Prognostic indicators in primary biliary cirrhosis: significance of revised IAHG (International Autoimmune Hepatitis Group) score

Ho Eun Jung, Jae Young Jang, Soung Won Jeong, Jin Nyoung Kim, Hee Yoon Jang, Yun Ju Cho, Sung Ae Woo, Sae Hwan Lee, Sang Gyune Kim, Sang-Woo Cha, Young Seok Kim, Young Deok Cho, Hong Soo Kim, Boo Sung Kim

Clin Mol Hepatol. 2012;18(4):375-382. Published online December 21, 2012

DOI: https://doi.org/10.3350/cmh.2012.18.4.375

View: 10740 Download: 65 Crossref: 7

The clinical features of drug-induced liver injury observed through liver biopsy: focus on relevancy to autoimmune hepatitis

Hye Young Ju, Jae Young Jang, Soung Won Jeong, Sung Ae Woo, Min Gyu Kong, Hee Yoon Jang, Sae Hwan Lee, Sang Gyune Kim, Sang-Woo Cha, Young Seok Kim, Young Deok Cho, So Young Jin, Hong Soo Kim, Boo Sung Kim

Clin Mol Hepatol. 2012;18(2):213-218. Published online June 26, 2012

DOI: https://doi.org/10.3350/cmh.2012.18.2.213

View: 9015 Download: 124 Crossref: 10

1 |

Viewed By 5356	Prognostic value of ultra-low-pass whole-genome sequencing of circulating tumor DNA in hepatocellular carcinoma under systemic treatment
Viewed By 5304	MAFLD: How is it different from NAFLD?
Viewed By 5205	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 3891	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Viewed By 3849	Global incidence and prevalence of nonalcoholic fatty liver disease

Cited By 114	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 103	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Cited By 76	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 65	Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach
Cited By 52	MAFLD: How is it different from NAFLD?

Search